| dc.contributor.author |
Desta, Bitsiet |
|
| dc.date.accessioned |
2025-03-26T12:30:20Z |
|
| dc.date.available |
2025-03-26T12:30:20Z |
|
| dc.date.issued |
2023 |
|
| dc.identifier.citation |
Submitted by iphce iphce (iphce-e@gmail.com) on 2025-03-26T12:30:20Z
No. of bitstreams: 0 |
en_US |
| dc.identifier.citation |
Made available in DSpace on 2025-03-26T12:30:20Z (GMT). No. of bitstreams: 0
Previous issue date: 2023 |
en_US |
| dc.identifier.uri |
https://etd.aau.edu.et/items/29ac5d18-d240-4e7e-b89a-8a0aaf384a85 |
|
| dc.description.abstract |
Cancer is one of the most common causes of morbidity and mortality in the world.
Around the globe, 19.3 million new cases of cancer were diagnosed in 2020, while about ten
million people died from cancer. Patients receiving myelosuppressive chemotherapy for cancer
face the risk of developing chemotherapy-induced neutropenia, which puts them at risk for serious
consequences like febrile neutropenia. |
en_US |
| dc.language.iso |
en_US |
en_US |
| dc.subject |
Cancer care |
|
| dc.title |
Incidence and determinant factors of Neutropenia among cancer patients receiving chemotherapy at Public Hospitals, Addis Ababa, Ethiopia, 2023 |
en_US |
| dc.title.alternative |
Incidence and determinant factors of Neutropenia among cancer patients receiving chemotherapy at Public Hospitals, Addis Ababa, Ethiopia, 2023 |
en_US |
| dc.type |
Thesis |
S |
| dc.type |
Thesis |
en_US |